S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
NYSE:PEAK

Healthpeak Properties (PEAK) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
N/A
50-Day Range
$16.18
$20.73
52-Week Range
N/A
Volume
9.98 million shs
Average Volume
7.81 million shs
Market Capitalization
$9.36 billion
P/E Ratio
30.54
Dividend Yield
7.02%
Price Target
$23.06

Healthpeak Properties MarketRank™ Stock Analysis

Analyst Rating
Hold
2.25 Rating Score
Upside/​Downside
∞ Upside
$23.06 Price Target
Short Interest
N/A
Dividend Strength
Moderate
Based on Four Factors
Sustainability
-1.84
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
Acquiring Shares
$300,780 Bought Last Quarter
Proj. Earnings Growth
6.78%
From $1.77 to $1.89 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.36 out of 5 stars

Finance Sector

448th out of 851 stocks

Real Estate Investment Trusts Industry

93rd out of 180 stocks

PEAK stock logo

About Healthpeak Properties Stock (NYSE:PEAK)

Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.

PEAK Stock News Headlines

Scotiabank Keeps Their Buy Rating on Healthpeak Properties (DOC)
Double your money before lunch?
Unlike bacterial infections, viral infections can be difficult to treat with medicine. Usually, if you've got a virus, your doctor's best advice is to simply rest and allow your immune system to fight back. Antiviral medications prevent viruses from reproducing, but they can't actually stop the virus. However, scientists may have just found a new way to fight back.
My 'Sweet 16' REITs Revealed
Double your money before lunch?
Unlike bacterial infections, viral infections can be difficult to treat with medicine. Usually, if you've got a virus, your doctor's best advice is to simply rest and allow your immune system to fight back. Antiviral medications prevent viruses from reproducing, but they can't actually stop the virus. However, scientists may have just found a new way to fight back.
Healthpeak Properties Inc DOC
PEAK Oct 2024 17.500 call
Invest Like Bill Gates with These REITs
American Homes 4 Rent Set to Join S&P MidCap 400
Healthpeak Properties Inc.
See More Headlines
Receive PEAK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Healthpeak Properties and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/08/2024
Ex-Dividend for 2/26 Dividend
2/13/2024
Dividend Payable
2/26/2024
Today
4/21/2024
Next Earnings (Estimated)
4/25/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Finance
Industry
Real estate investment trusts
Sub-Industry
N/A
Employees
193
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$23.06
High Stock Price Target
$32.00
Low Stock Price Target
$17.50
Consensus Rating
Hold
Rating Score (0-4)
2.25
Research Coverage
8 Analysts

Profitability

Net Income
$306.01 million
Pretax Margin
14.44%

Debt

Sales & Book Value

Annual Sales
$2.18 billion
Book Value
$12.57 per share

Miscellaneous

Free Float
546,133,000
Market Cap
$9.36 billion
Optionable
Optionable
Beta
1.01
The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives


PEAK Stock Analysis - Frequently Asked Questions

Should I buy or sell Healthpeak Properties stock right now?

8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Healthpeak Properties in the last twelve months. There are currently 1 sell rating, 4 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" PEAK shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in PEAK, but not buy additional shares or sell existing shares.
View PEAK analyst ratings
or view top-rated stocks.

What is Healthpeak Properties' stock price target for 2024?

8 brokerages have issued twelve-month price objectives for Healthpeak Properties' stock. Their PEAK share price targets range from $17.50 to $32.00. On average, they anticipate the company's stock price to reach $23.06 in the next year.
View analysts price targets for PEAK
or view top-rated stocks among Wall Street analysts.

When is Healthpeak Properties' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, April 25th 2024.
View our PEAK earnings forecast
.

How were Healthpeak Properties' earnings last quarter?

Healthpeak Properties, Inc. (NYSE:PEAK) issued its quarterly earnings data on Thursday, February, 8th. The company reported $0.13 earnings per share for the quarter, missing analysts' consensus estimates of $0.45 by $0.32. The business earned $553.65 million during the quarter, compared to analyst estimates of $553.77 million. Healthpeak Properties had a trailing twelve-month return on equity of 4.34% and a net margin of 13.97%. The firm's revenue for the quarter was up 5.6% compared to the same quarter last year. During the same quarter last year, the company earned $0.44 EPS.

How often does Healthpeak Properties pay dividends? What is the dividend yield for Healthpeak Properties?

Healthpeak Properties declared a quarterly dividend on Wednesday, January 31st. Stockholders of record on Wednesday, February 14th will be given a dividend of $0.30 per share on Monday, February 26th. This represents a $1.20 annualized dividend and a yield of ∞. The ex-dividend date of this dividend is Tuesday, February 13th.
Read our dividend analysis for PEAK
.

Is Healthpeak Properties a good dividend stock?

Healthpeak Properties (NYSE:PEAK) pays an annual dividend of $1.20 per share and currently has a dividend yield of 7.02%. PEAK has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 214.29%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, PEAK will have a dividend payout ratio of 63.49% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for PEAK.

What ETFs hold Healthpeak Properties' stock?

ETFs with the largest weight of Healthpeak Properties (NYSE:PEAK) stock in their portfolio include WisdomTree New Economy Real Estate Fund (WTRE) and Emerge EMPWR Sustainable Global Core Equity ETF (EMZA).iShares Cohen & Steers REIT ETF (ICF).

What guidance has Healthpeak Properties issued on next quarter's earnings?

Healthpeak Properties issued an update on its FY 2024 earnings guidance on Friday, March, 29th. The company provided EPS guidance of 1.730-1.790 for the period, compared to the consensus earnings per share estimate of 1.780. The company issued revenue guidance of -.

What is Thomas M. Herzog's approval rating as Healthpeak Properties' CEO?

10 employees have rated Healthpeak Properties Chief Executive Officer Thomas M. Herzog on Glassdoor.com. Thomas M. Herzog has an approval rating of 100% among the company's employees. This puts Thomas M. Herzog in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Who are Healthpeak Properties' major shareholders?

Healthpeak Properties' stock is owned by a variety of retail and institutional investors. Top institutional investors include Brookstone Capital Management (0.09%), Pensionfund DSM Netherlands (0.05%), Vert Asset Management LLC (0.04%), Pensionfund Sabic (0.02%), Kingswood Wealth Advisors LLC (0.01%) and Atlas Brown Inc. (0.00%). Insiders that own company stock include Christine Garvey, Sara Grootwassink Lewis, Scott M Brinker and Thomas Klaritch.
View institutional ownership trends
.

This page (NYSE:PEAK) was last updated on 4/21/2024 by MarketBeat.com Staff

From Our Partners